This Credo Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Credo Technology
AgomAb Therapeutics NV ADR
SpaceX
Conexeu Sciences, Inc.
Faeth Therapeutics, Inc.
Credo Technology CRDO | 0.00 | |
AgomAb Therapeutics NV ADR AGMB | 0.00 | |
SpaceX SPCX | 0.00 | |
Conexeu Sciences, Inc. CNXU | 0.00 | |
Faeth Therapeutics, Inc. FTH | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Swayampakula Ramakanth initiated coverage on Conexeu Sciences Inc (NASDAQ:CNXU) with a Buy rating and announced a price target of $20. Conexeu Sciences shares closed at $13.28 on Thursday. See how other analysts view this stock.
- Evercore ISI Group analyst Mark Lipacis initiated coverage on Credo Technology Group Holding Ltd (NASDAQ:CRDO) with an Outperform rating and announced a price target of $325. Credo Technology shares closed at $271.83 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Patrick R. Trucchio initiated coverage on Agomab Therapeutics NV (NASDAQ:AGMB) with a Buy rating and announced a price target of $35. AgomAb Therapeutics shares closed at $10.98 on Thursday. See how other analysts view this stock.
- Keybanc analyst Michael Leshock initiated coverage on Space Exploration Technologies Corp (NASDAQ:SPCX) with a Sector Weight rating. SpaceX shares closed at $185.00 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Patrick R. Trucchio initiated coverage on Faeth Therapeutics, Inc. (NASDAQ:FTH) with a Buy rating and announced a price target of $60. Faeth Therapeutics shares closed at $17.82 on Thursday. See how other analysts view this stock.
Considering buying CRDO stock? Here’s what analysts think:
Photo via Shutterstock